• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,140.45CD20 down 0.37 percent0.37%BTC$77,144.63BTC down 0.33 percent0.33%ETH$2,384.85ETH down 1.37 percent1.37%XRP$1.35XRP down 0.29 percent0.29%SOL$99.90SOL down 0.089 percent0.089%
Prices > BMY
BMYBMY
$67.70Up 1.17 percent, +$0.781.17%($0.78)
As of today at 4:00 PM ET

Key Stats

Volume (24h)4,600,034
Day's Range$66.64-$67.72

About Bristol-Myers Squibb Co.

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Website
bms.com
Industry
PHARMACEUTICAL PREPARATIONS
Full-time Employees
32,500
Headquarters
PRINCETON
IPO Date
Jun 23, 1952
Loading chart...

Similar Stocks

S
S&P 500 ETFSPY
$764.85
Up 0.40 percent0.40%($3.07)
BullishBLSH
$32.88
Down 0.54 percent0.54%($0.18)
Coinbase Global IncCOIN
$174.88
Down 1.10 percent1.10%($1.94)
Circle Internet GroupCRCL
$88.63
Down 0.95 percent0.95%($0.85)
PE Ratio41.79
EPS1.62
Net Income (FY)$7.05B
Revenue (FY)$48.19B
Market Cap$136.474B
52-Week Range$42.52-$68.64
24 hours5 days1 monthYTD1 yearAll time
Up 1.17 percent1.17%
Up 1.12 percent1.12%
Up 3.66 percent3.66%
Up 24.88 percent24.88%
Up 43.49 percent43.49%
—

Latest BMY News

Is BioNTech Stock a No-Brainer Buy on the Dip?
4 hrs agoNeutral
(opens in a new tab)

Is BioNTech Stock a No-Brainer Buy on the Dip?

5 hrs agoNeutral(opens in a new tab)

Can CYTK's Aficamten Strengthen Its HCM Growth Prospects?

7 hrs agoPositive(opens in a new tab)

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

1 day agoNeutral(opens in a new tab)

Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal

2 days agoNeutral(opens in a new tab)

From Padcev to PF-08634404: Pfizer's Oncology Growth Push

4 days agoPositive(opens in a new tab)

Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors

5 days agoPositive(opens in a new tab)

Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider